Clinical Trials Logo

Dyslipidemia clinical trials

View clinical trials related to Dyslipidemia.

Filter by:

NCT ID: NCT03861533 Not yet recruiting - Dyslipidemia Clinical Trials

GOAL International QuERI

GOAL QuERI
Start date: April 1, 2019
Phase:
Study type: Observational [Patient Registry]

This Quality Enhancement Research Initiative (QuERI) is a knowledge translation medical practice activity based on decision making support through feedback to physicians on their management of dyslipidemia in order to achieve guidelines recommended LDL-C levels in high risk patients. Physician interaction has three distinct components: 1. Capture of data as reported by participating physician; 2. Highlight (by providing feedback) where management may be optimized based on guidelines or recommendations; 3. Identify challenges faced by physicians resulting in the care gap..

NCT ID: NCT03606824 Recruiting - Dyslipidemia Clinical Trials

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

In ASCVD patients complicated with subclinical hypothyroidism, the percentage of those who did not reach the target of lipid-lowering therapy (LDL-C>1.8mmol/L) is usually higher than that in population with normal thyroid function. The present study aims to randomly compare two lipid-lowering therapeutic strategies (statins only vs. statins combined with thyroid hormone supplement).

NCT ID: NCT03527069 Not yet recruiting - Dyslipidemia Clinical Trials

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Start date: May 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Isolated Hypertriglyceridemia and Dyslipidemia Treatment

NCT ID: NCT03403283 Recruiting - Dyslipidemia Clinical Trials

Dyslipidemia and Diabetic Retinopathy

D&D
Start date: January 2014
Phase:
Study type: Observational

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

NCT ID: NCT03401580 Not yet recruiting - Hypertension Clinical Trials

Efficacy of Fixed-doses of Antihypertensive and Statin Drugs

Start date: January 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of different fixed-dose combination of Viena II in treatment of hypertension and dyslipidemia.

NCT ID: NCT03267329 Not yet recruiting - Hypertension Clinical Trials

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Start date: February 2018
Phase: Phase 4
Study type: Interventional

This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.

NCT ID: NCT03235362 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

Start date: August 7, 2017
Phase: Phase 1
Study type: Interventional

This is a phase 1, open label, multiple-dose, crossover clinical trial to investigate the pharmacokinetic drug interaction between YHR1705 and YHR1706 in healty male volunteers

NCT ID: NCT03210649 Completed - Dyslipidemia Clinical Trials

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Start date: March 7, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519

NCT ID: NCT03210532 Completed - Hypertension Clinical Trials

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Start date: October 7, 2016
Phase: Phase 3
Study type: Interventional

A Multicenter, Randomized, Double-blinded, Double-dummy, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Treatment with DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients with Hypertension and Dyslipidemia

NCT ID: NCT03203915 Active, not recruiting - Obesity Clinical Trials

Metabolic Response to Chardonnay Grape Pomace Powder

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

To determine if the addition of chardonnay grape pomace powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.